Plain language summary of SUNLIGHT: trifluridine/tipiracil and bevacizumab for refractory metastatic colorectal cancer

Gerald W Pragera The Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

Julien Taiebb The Department of Gastroenterology & Digestive Oncology, Georges Pompidou European Hospital, SIRIC Cancer Research for Personalized Medicine, Université Paris Cité, Paris, France

Marwan Fakihc City of Hope Comprehensive Cancer Center, Duarte, CA, USA

Fortunato Ciardiellod Dipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy

Eric Van Cutseme The Department of Digestive Oncology, University Hospitals Gasthuisberg & KU Leuven, Leuven, Belgium

Elena Élezf The Department of Medical Oncology, Vall d'Hebron Hospital Campus & Institute of Oncology, International Oncology Bureau–Quiron, Barcelona, Spain

Lucjan Wyrwiczg The Department of Oncology & Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Daniil Stroyakovskiyh Moscow City Oncology Hospital, Moscow Healthcare Department, Moscow, Russia

Gabor Lipositsi The Department of Oncology, Regional Hospital West Jutland, Herning, Denmark

Igor Bondarenkoj Dnipro State Medical University, Dnipro, Ukraine

Dominik P Modestk The Medical Department of Hematology, Oncology, & Cancer Immunology, Charité–Universitätsmedizin Berlin, Berlin, Germany

Nadia Amellall Servier, Suresnes, France

Josep Tabernerof The Department of Medical Oncology, Vall d'Hebron Hospital Campus & Institute of Oncology, International Oncology Bureau–Quiron, Barcelona, Spain

& for the SUNLIGHT Investigators show all

Plain language summary of SUNLIGHT: trifluridine/tipiracil and bevacizumab for refractory metastatic colorectal cancer

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Plain language summary of SUNLIGHT: trifluridine/tipiracil and bevacizumab for refractory metastatic colorectal cancer

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date